Related Experiment Video
Updated: Jun 16, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Motivational interviewing for adherence problems in cystic fibrosis.
Alistair J A Duff1, Gary J Latchford
1Clinical & Health Psychology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. alistair.duff@leedsth.nhs.uk
Improving adherence in cystic fibrosis (CF) requires effective communication. Motivational interviewing (MI) shows promise for enhancing patient adaptation and treatment adherence in CF care.
Area of Science:
- Medical adherence research
- Pulmonary medicine
- Behavioral science in healthcare
Background:
- Adherence to treatment regimens is crucial for managing chronic conditions like cystic fibrosis (CF).
- Various factors influence patient adherence, including communication dynamics within clinical settings.
- Motivational interviewing (MI) is a communication strategy with potential applications in improving health behaviors.
Purpose of the Study:
- To review factors influencing adherence in cystic fibrosis (CF).
- To examine the role of effective communication in CF clinical practice.
- To evaluate the evidence supporting motivational interviewing (MI) for enhancing adaptation and adherence in CF patients.
Main Methods:
- Literature review synthesizing existing research on CF adherence.
- Analysis of communication strategies in healthcare settings.
- Examination of studies on motivational interviewing (MI) effectiveness in chronic disease management.
Main Results:
- Effective communication is a key determinant of treatment adherence in CF.
- Motivational interviewing (MI) demonstrates potential for improving patient adaptation and adherence.
- Specific MI techniques can be integrated into routine CF care.
Conclusions:
- Enhancing communication, particularly through methods like MI, is vital for improving adherence in cystic fibrosis.
- Implementing MI in routine care can support better health outcomes for individuals with CF.
- Further research and clinical integration of MI are recommended for CF management.
More Related Videos
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs for Treatment of Constipation-Predominant IBS
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History